Glipizide Tablet
Product Images NDC 0615-8407

4 FDA label images from Ncs Healthcare Of Ky, Llc Dba Vangard Labs · Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 4 technical images submitted to the FDA as part of the official labeling for Glipizide (NDC 0615-8407). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Ncs Healthcare Of Ky, Llc Dba Vangard Labs, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Structural Formula Of Glipizide (Glipizide Tabs 5 mg 8407 10 mg 8408 1)

Structural Formula Of Glipizide (Glipizide Tabs 5 mg 8407 10 mg 8408 1)
Chemical structure of Glipizide, showing its molecular components including a pyridine ring, sulfonylurea group, and cyclohexyl group. The diagram displays the connectivity and arrangement of atoms within the molecule.*
FDA Label Image

Principal Display Panel (5 mg)

Principal Display Panel (5 mg)
Glipizide Tablets USP 5 mg oral tablets packaging label from NCS HealthCare of KY, LLC dba Vangard Labs. The label indicates a quantity of 30 tablets and notes packaging by Vanguard Labs in Glasgow, KY. The label includes multiple small barcode sections for institutional use, storage instructions to keep at controlled room temperature, and dispensing in a tight container. Manufactured by Watson for Teva, the label also bears lot and expiration placeholders.*
FDA Label Image

Principal Display Panel (5 mg Unit Dose)

Principal Display Panel (5 mg Unit Dose)
Label sheet containing multiple identical Glipizide Tablets USP 5 mg barcode labels by Vangard Labs, Glasgow, KY. Each label includes the drug name, strength, lot number placeholder, expiration date placeholder, and barcode. Below is a full packaging label for Glipizide Tablets USP 5 mg, quantity 30, with storage instructions and manufacturer details showing Watson for Teva and repackaged by Vangard Labs.*
FDA Label Image

Principal Display Panel (10 mg)

Principal Display Panel (10 mg)
Label for Glipizide Tablets USP 10 mg, an oral tablet manufactured by Watson for Teva and packaged by Vangard Labs in Glasgow, KY. The label includes lot number and expiration placeholders, a quantity of 30 tablets, and instructions for institutional use only. Multiple small labels with identical product information and barcodes are shown, intended for packaging. Storage instructions mention controlled room temperature (20-25°C).*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.